RealReal price target raised to $5.50 from $4 at BTIG
BTIG analyst Marvin Fong raised the firm’s price target on RealReal (REAL) to $5.50 from $4 and keeps a Buy rating on the shares. The firm ...
Fintel on MSN11h
BTIG Upgrades Aclaris Therapeutics (ACRS)
Fintel reports that on November 19, 2024, BTIG upgraded their outlook for Aclaris Therapeutics (NasdaqGS:ACRS) from Neutral ...
Fintel on MSN1d
BTIG Initiates Coverage of VYNE Therapeutics (VYNE) with Buy Recommendation
Fintel reports that on November 18, 2024, BTIG initiated coverage of VYNE Therapeutics (NasdaqCM:VYNE) with a Buy ...
Business Wire1d
BTIG to Host Digital Health Forum on November 25, 2024
NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...
bovnews3d
How Does Synchrony Financial (SYF) Stack Up Against Its Industry Peers?
On Friday, Synchrony Financial (SYF) stock saw a modest uptick, ending the day at $64.98 which represents a slight increase of $0.09 or 0.14% from the prior close of $64.89. The stock opened at $64.99 ...
Uber management to meet with BTIG
Digital Services Analyst Fuller holds a group dinner meeting with CFO Mahendra-Rajah and VP Subramanian in Florida on November 20 hosted by ...
bovnews4d
Why Did BTIG Research Give Opendoor Technologies Inc (OPEN) Stock Neutral Rating?
On Thursday, Opendoor Technologies Inc (OPEN) stock saw a decline, ending the day at $1.77 which represents a decrease of $-0.04 or -2.21% from the prior close of $1.81. The stock opened at $1.81 and ...